PMID- 10605038 OWN - NLM STAT- MEDLINE DCOM- 20000119 LR - 20190515 IS - 0022-1767 (Print) IS - 0022-1767 (Linking) VI - 164 IP - 1 DP - 2000 Jan 1 TI - Kinetics and cellular origin of cytokines in the central nervous system: insight into mechanisms of myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis. PG - 419-26 AB - Experimental autoimmune encephalomyelitis induced by myelin oligodendrocyte glycoprotein (MOG) in C57BL/6 (H-2b) mice is characterized by early (day 12) acute paralysis, followed by a sustained chronic clinical course that gradually stabilizes. Extensive inflammation and demyelination coincide with clinical signs of disease. To identify the mechanisms of these processes, individual proinflammatory and anti-inflammatory cytokines and chemokines were studied. Sensitive single-cell assays were utilized to determine the cellular origin and kinetics of cytokine production in the CNS. Immunization with MOG35-55 peptide resulted in priming of both Th1 (lymphotoxin, IFN-gamma, and TNF-alpha) and Th2 (IL-4) cells in the spleen. However, only Th1 cells were apparent in the CNS. CD4 T cells that produced IFN-gamma or TNF-alpha were present in the CNS by day 7 after immunization with MOG35-55, peaked at day 20, and then waned. TNF-alpha was also produced in the CNS by Mac-1+ cells. On days 7 and 10 after immunization, the TNF-alpha-producing Mac1+ cells were predominantly microglia. By day 14, a switch occurred in that the Mac1+ TNF-alpha-producing cells had the phenotype of infiltrating macrophages. RANTES, IFN-inducible protein 10 (IP-10), and monocyte chemotactic protein 1 chemokine mRNA were detected in the CNS by day 8 after immunization. The early presence of monocyte chemotactic protein 1 (MCP-1) in the CNS provides a mechanism for the recruitment of macrophages. These data implicate TNF-alpha production by a continuum of T cells, microglia, and macrophages at various times during the course of disease. The importance of Th1 cytokines is highlighted, with little evidence for a role of Th2 cytokines. FAU - Juedes, A E AU - Juedes AE AD - Department of Epidemiology and Public Health, Section of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA. FAU - Hjelmstrom, P AU - Hjelmstrom P FAU - Bergman, C M AU - Bergman CM FAU - Neild, A L AU - Neild AL FAU - Ruddle, N H AU - Ruddle NH LA - eng GR - TG AI 07019/AI/NIAID NIH HHS/United States PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - J Immunol JT - Journal of immunology (Baltimore, Md. : 1950) JID - 2985117R RN - 0 (Chemokines) RN - 0 (Cytokines) RN - 0 (Inflammation Mediators) RN - 0 (Mog protein, mouse) RN - 0 (Myelin Proteins) RN - 0 (Myelin-Associated Glycoprotein) RN - 0 (Myelin-Oligodendrocyte Glycoprotein) RN - 0 (Tumor Necrosis Factor-alpha) RN - 82115-62-6 (Interferon-gamma) SB - IM MH - Amino Acid Sequence MH - Animals MH - Central Nervous System/cytology/*immunology/*metabolism MH - Chemokines/biosynthesis MH - Cytokines/*biosynthesis MH - Encephalomyelitis, Autoimmune, Experimental/etiology/*immunology/metabolism MH - Female MH - Immunophenotyping MH - Inflammation Mediators/metabolism MH - Injections, Subcutaneous MH - Interferon-gamma/biosynthesis/metabolism MH - Kinetics MH - Lymphocyte Activation MH - Macrophages/immunology/metabolism MH - Mice MH - Mice, Inbred C57BL MH - Microglia/immunology/metabolism MH - Molecular Sequence Data MH - Myelin Proteins MH - Myelin-Associated Glycoprotein/administration & dosage/*immunology MH - Myelin-Oligodendrocyte Glycoprotein MH - Spleen/cytology/immunology/metabolism MH - Th1 Cells/immunology/metabolism MH - Th2 Cells/immunology/metabolism MH - Tumor Necrosis Factor-alpha/biosynthesis/metabolism EDAT- 1999/12/22 00:00 MHDA- 1999/12/22 00:01 CRDT- 1999/12/22 00:00 PHST- 1999/12/22 00:00 [pubmed] PHST- 1999/12/22 00:01 [medline] PHST- 1999/12/22 00:00 [entrez] AID - ji_v164n1p419 [pii] AID - 10.4049/jimmunol.164.1.419 [doi] PST - ppublish SO - J Immunol. 2000 Jan 1;164(1):419-26. doi: 10.4049/jimmunol.164.1.419.